GLP-1 medications such as Ozempic, Wegovy and Zepbound were developed for blood-sugar control and now support weight loss, metabolic health and inflammation.
What microdosing means
Taking significantly smaller doses than the manufacturer's label — prescribed and gradually adjusted by a medical professional to fit your goals, tolerance and physiology. The aim is to minimize side effects rather than chase dramatic appetite suppression.
What it's used for
- Weight management. The drug mimics the GLP-1 hormone, slowing stomach emptying and reducing appetite; trials show greater loss than diet and exercise alone.
- Metabolic health. Improved insulin resistance and blood sugar, often before weight loss.
- Inflammation. Anti-inflammatory effects can begin within hours; a 2025 study linked GLP-1 use in diabetics to 10–20% lower inflammation and reduced risk of heart failure and Alzheimer's.
About compounded GLP-1s
Because FDA-approved pens are hard to split safely, providers often order compounded GLP-1s. They grew popular during the 2022 shortages but lack the same clinical trials — so a trusted, licensed provider matters.
Why the measured approach
Fewer gastrointestinal side effects (the main reason people quit), more gradual results that avoid the drawn look of rapid loss, and lower cost than full doses that can exceed $1,000 a month.
Never self-dose or follow unlicensed advice. A provider tailors your dosage and adjusts it if side effects or cost become a concern. ThrIVe offers medically supervised weight-loss therapy with telehealth consults across our Houston and Dallas–Fort Worth lounges — learn more.
